Su et al. [87] demonstrated that miR-9 inhibited both E-cadherin and beta 1-integrin in human lesional vitiligo specimens without affecting the levels of laminin, beta-catenin, and collagen IV in the skin of patients with vitiligo [87]. The gene discussed is ITGB1; the disease is vitiligo.